Your browser is no longer supported. Please, upgrade your browser.
Settings
RMED Ra Medical Systems, Inc. daily Stock Chart
RMED [NYSE]
Ra Medical Systems, Inc.
Index- P/E- EPS (ttm)-2.73 Insider Own1.70% Shs Outstand12.29M Perf Week4.60%
Market Cap53.09M Forward P/E- EPS next Y-1.59 Insider Trans- Shs Float6.87M Perf Month-3.14%
Income-30.80M PEG- EPS next Q-0.61 Inst Own21.30% Short Float5.32% Perf Quarter-40.82%
Sales6.30M P/S8.43 EPS this Y-116.90% Inst Trans-34.07% Short Ratio2.92 Perf Half Y-46.93%
Book/sh4.71 P/B0.92 EPS next Y20.30% ROA-98.40% Target Price10.00 Perf Year-
Cash/sh4.48 P/C0.96 EPS next 5Y- ROE-120.00% 52W Range3.34 - 22.00 Perf YTD-45.66%
Dividend- P/FCF- EPS past 5Y- ROI-46.10% 52W High-80.36% Beta-
Dividend %- Quick Ratio11.50 Sales past 5Y- Gross Margin32.80% 52W Low29.54% ATR0.42
Employees114 Current Ratio11.90 Sales Q/Q70.00% Oper. Margin- RSI (14)50.14 Volatility10.78% 10.26%
OptionableNo Debt/Eq0.02 EPS Q/Q-395.30% Profit Margin- Rel Volume0.34 Prev Close4.69
ShortableYes LT Debt/Eq0.01 EarningsMay 13 AMC Payout- Avg Volume125.30K Price4.32
Recom2.00 SMA20-2.09% SMA502.23% SMA200-43.56% Volume42,753 Change-7.89%
Nov-02-18Initiated Maxim Group Buy $23
May-21-19 07:27PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ra Medical Systems, Inc. - RMED GlobeNewswire
May-20-19 04:30PM  DABRA Laser to be Presented as a Frontline Therapy for CLI at the 2019 SCAI Scientific Sessions Business Wire
May-18-19 08:22AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ra Medical Systems, Inc. - RMED ACCESSWIRE
May-17-19 03:00PM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ra Medical Systems, Inc. (RMED) GlobeNewswire +5.26%
10:00AM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ra Medical Systems, Inc. (RMED) ACCESSWIRE
May-16-19 07:10PM  Glancy Prongay & Murray LLP Continues Investigation on Behalf of Ra Medical Systems, Inc. Investors Business Wire +10.41%
05:35PM  Ra Medical Systems Sues Strata Skin Sciences for False, Misleading, and Disparaging Statements in Connection with Ra Medicals Initial Public Offering Business Wire
02:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ra Medical Systems, Inc. - RMED GlobeNewswire
May-14-19 09:01AM  Ra Medical Systems Announces Platinum Partnership with OEIS: Demonstrating Commitment to Deliver High-Quality Care in Office Interventional Suites Business Wire +7.73%
May-13-19 04:05PM  Ra Medical Systems Reports First Quarter 2019 Financial Results Business Wire
May-10-19 02:06PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Ra Medical Systems, Inc. Investors Business Wire
May-09-19 05:07PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Ra Medical Systems, Inc. Investors (RMED) Business Wire
May-08-19 09:30PM  Bragar Eagel & Squire, P.C. is Investigating Ra Medical Systems, Inc. (NYSE: RMED) on Behalf of Ra Medical Stockholders and Encourages Ra Medical Investors to Contact the Firm GlobeNewswire
01:41PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Ra Medical Systems, Inc. Investors (RMED) Business Wire
May-06-19 07:00AM  Ra Medical to Hold First Quarter 2019 Conference Call on May 13, 2019 Business Wire
Apr-29-19 02:25PM  Ra Medical Systems, Inc. (NYSE:RMED): What Can We Expect From This High Growth Stock? Simply Wall St. -10.44%
Apr-11-19 09:01AM  DABRA Excimer Laser Atherectomy to be Presented in Key Events at Charing Cross International Symposium Business Wire
Mar-14-19 04:05PM  Ra Medical Systems Reports 2018 Fourth Quarter and Full Year Financial Results Business Wire
Mar-07-19 04:30PM  New Study Shows DABRA Laser System Achieved 94% Success Rate in Patients with Peripheral Artery Disease Business Wire
07:00AM  Ra Medical to Hold 2018 Fourth Quarter and Full Year Conference Call on March 14, 2019 Business Wire
Feb-20-19 08:30AM  New Data Presented at LINC 2019 Demonstrates Acute Success with DABRA Excimer Laser System for the Treatment of Peripheral Artery Disease Business Wire
Jan-02-19 08:00AM  Ra Medical Systems to Present at Biotech Showcase 2019 on January 8 during Annual JPMorgan Healthcare Conference in San Francisco Business Wire
Dec-26-18 02:59PM  Analysts Expect Breakeven For Ra Medical Systems, Inc. (NYSE:RMED) Simply Wall St.
Dec-17-18 08:00AM  Ra Medical Systems Appoints Thomas Fogarty as Chief Commercial Officer Business Wire
Nov-13-18 04:15PM  Ra Medical Systems Reports Third Quarter 2018 Results Business Wire
Oct-30-18 04:15PM  Ra Medical Systems to Report Third Quarter 2018 Results on November 13, 2018 Business Wire
Oct-24-18 04:15PM  Ra Medical Systems Appoints Dan Horwood as General Counsel Business Wire
Oct-01-18 05:03PM  Ra Medical Systems Announces Closing of Initial Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares Business Wire -18.63%
Sep-27-18 03:09PM  Ra Medical's stock soars to pace NYSE gainers after public debut MarketWatch
Sep-26-18 11:13PM  Ra Medical Systems Announces Pricing of Initial Public Offering Business Wire
Sep-22-18 04:15PM  The IPO Outlook For The Week: Smart Appliances, A Language App and Drugmakers Benzinga
Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.